1. What is the projected Compound Annual Growth Rate (CAGR) of the Animal Healthcare Market?
The projected CAGR is approximately 6%.
Market
Insights
Reports delivered globally, covering a wide range of industries and sectors.
Clients who trust our expertise and rely on our insights for business decisions.
Managed Reports, ensuring seamless updates and premium service.
Satisfied Customers, committed to delivering exceptional value and quality.
Animal Healthcare Market by Product (Pharmaceuticals, Medical devices, Veterinary services), by Animal Type (Companion animals, Livestock animals), by Distribution Channel (Veterinary hospital pharmacy, E-commerce, Retail pharmacy), by North America (U.S., Canada), by Europe (Germany, UK, France, Spain, Italy, Poland, Netherlands, Rest of Europe), by Asia Pacific (China, Japan, India, Australia, South Korea, Taiwan, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Argentina, Rest of Latin America), by Middle East and Africa (South Africa, GCC Countries, Israel, Rest of Middle East and Africa) Forecast 2025-2033
The size of the Animal Healthcare Market was valued at USD 186.1 Billion in 2023 and is projected to reach USD 279.83 Billion by 2032, with an expected CAGR of 6% during the forecast period. The Animal Healthcare industry is centered on creating and offering products and services to enhance the health and wellness of animals, such as pets, livestock, and poultry. This market includes a variety of offerings like vaccines, pharmaceuticals, diagnostics, feed additives, and medical devices, all aimed at preventing, treating, and managing diseases, while also improving animals' overall health and productivity. The increasing need for top-quality animal-derived goods, along with the growing concern for animal well-being, is fueling market expansion. Moreover, the growing number of pets being kept as companions, the growth of animal agriculture, and the utilization of cutting-edge veterinary tools are also driving up the need. With advancements in biologics, genetic testing, and telemedicine, the animal healthcare industry is increasingly focused on preventive care. The Animal Healthcare market is projected to grow substantially due to increased global demand for healthy animals and animal products, as stakeholders prioritize sustainable farming, disease prevention, and animal nutrition.
The animal healthcare market is moderately concentrated, with the top 10 players accounting for approximately 50% of the market share. Key characteristics include:
Product:
Animal Type:
Distribution Channel:
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6% from 2019-2033 |
Segmentation |
|
Note* : In applicable scenarios
Primary Research
Secondary Research
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
The projected CAGR is approximately 6%.
Key companies in the market include B. Braun Vet Care (B Braun Melsungen AG), Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals, Elanco Animal Health, Endovac Animal Health, HIPRA, IDEXX Laboratories, Inc., Medtronic plc, Merck & Co, Inc., Neogen Corporation, Sklar Surgical Instruments, Symrise, Vetoquinol SA, Virbac SA, Zoetis, Inc..
The market segments include Product, Animal Type, Distribution Channel.
The market size is estimated to be USD 186.1 Billion as of 2022.
Increasing pet adoption for companionship. Increasing support offered by government and public organizations for animal care. Growing demand for online veterinary pharmacies. Increase in animal healthcare expenditure.
N/A
High cost associated with animal healthcare drugs. Low out of pocket expenditure on pet healthcare in developing countries.
In December 2023, Neogen Corporation partnered with the Cat Fanciers' Association (CFA), a renowned authority in feline advocacy. This collaboration focuses on enhancing genomic products for CFA members, promoting My CatScan DNA testing services through marketing, education, and promotion, driving innovation and awareness in feline genetics.
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4,850, USD 5,350, and USD 8,350 respectively.
The market size is provided in terms of value, measured in Billion.
Yes, the market keyword associated with the report is "Animal Healthcare Market," which aids in identifying and referencing the specific market segment covered.
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
To stay informed about further developments, trends, and reports in the Animal Healthcare Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
See the similar reports
Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.
Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.
We use cookies to enhance your experience.
By clicking "Accept All", you consent to the use of all cookies.
Customize your preferences or read our Cookie Policy.